Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02583425 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of DFN-11 Injection in Medication Overuse Headache
A Phase 2 study, sponsored by Dr. Reddy's Laboratories Limited.
- Terminated
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT02583425 is a Phase 2 study that was terminated before completion, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 27 participants.
The verdict
NCT02583425, a Phase 2 study, was terminated before completion, sponsored by Dr. Reddy's Laboratories Limited.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
Efficacy and Safety Pilot Study of DFN-11 Injection in Medication Overuse Headache
Interventions
- DRUG DFN-11 Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02583425
The ClinicalTrials.gov registry entry for NCT02583425 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DFN-11 Injection is the first listed.
NCT02583425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02583425 about?
NCT02583425 is a clinical study titled "Pilot Study of DFN-11 Injection in Medication Overuse Headache". Efficacy and Safety Pilot Study of DFN-11 Injection in Medication Overuse Headache
What is the current status of trial NCT02583425?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2015-09. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02583425?
The interventions under investigation include: DFN-11 Injection (DRUG).
Who is sponsoring clinical trial NCT02583425?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.